Advances in drug resistance mechanisms of multiple myeloma: reports from the 55th ASH annual meeting
10.3760/cma.j.issn.1009-9921.2014.03.002
- VernacularTitle:多发性骨髓瘤耐药机制相关研究进展:第55届美国血液学会年会报道
- Author:
Meirong ZANG
;
Lugui QIU
- Publication Type:Journal Article
- Keywords:
Multiple myeloma;
Drug resistance;
ASH annual meeting
- From:
Journal of Leukemia & Lymphoma
2014;23(3):133-136
- CountryChina
- Language:Chinese
-
Abstract:
Multiple myloma represents the second most common blood cancer.Although new drugs emerge rapidly,multiple myeloma is still incurable.Drug resistance is one of the main causes of myeloma recurrence and relapse.In this paper,advances about the drug resistance mechanisms reported in the 55th ASH annual meeting are summarized.
